Ruby Williams, M.D. Drugs, Alcohol and Sleep February 24, 2018

Similar documents
Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

Disclosure. Objective 1. Objective 2. Naval Health Center New England. Objective 3. APNA 27th Annual Conference Session 1036: October 9, 2013

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Treating sleep disorders

Insomnia: Updates in Medical Management. Michael Newnam M.D.

DRUGS THAT ACT IN THE CNS

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

Diagnosis and treatment of sleep disorders

INSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM

PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES

Anti-Depressant Medications

Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.

Available Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA

Quick Guide to Common Antidepressants-Adults

Insomnia. Dr Terri Henderson MBChB FCPsych

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry

ANTI-DEPRESSANT MEDICATIONS

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. baclofen 73 basal forebrain nuclei 174

Treating Depression in Adults

Insomnia. St. Joseph s Annual Family Practice Refresher March 1, Robert J. Ostrander, M.D

Depression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness

Management of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors*

Presentation is Being Recorded

Medications Guide: Public Speaking And Social Anxiety

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded

Schedule FDA & literature based indications

Guide to Psychiatric Medications for Children and Adolescents

The Medical Letter. on Drugs and Therapeutics. Usual Adult Hypnotic Dose 1,2 Some Adverse Effects Comments Cost 3

Narcolepsy. Jon R. Doud, MD Pulmonary Physician Midwest Center for Sleep Disorders Aurora, IL

Children s Hospital Of Wisconsin

Psychobiology Handout

Modern Management of Sleep Disorders

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Modern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before

PHARMACOLOGY OF SLEEP

SLEEP AND MELATONIN SECRETION ABNORMALITIES IN CHILDREN & ADOLESCENTS WITH FASD DR. S. GORIL DR. D. ZALAI DR. C. SHAPIRO DR. L. A.

LIBERTY SLEEP ASSOCIATES, LLC SLEEP DISORDERS CENTER

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

Depression & Anxiety in Adolescents

TOP 10 LIST OF SLEEP QUESTIONS. Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children

TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE

SLEEP DISORDERS. Kenneth C. Sassower, MD Division of Sleep Medicine; Department of Neurology Massachusetts General Hospital for Children

Michelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax:

Antidepressants Choosing the Right One

Antidepressant Selection in Primary Care

Diana Corzine, MD ABMS Sleep Chief MT VA Sleep Medicine Common Sleep Disorders

Sleep and Parkinson's Disease

Earl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles

TREATMENT OF DEPRESSION IN LATE LIFE. Robert Kohn, MD

Introduction to Drug Treatment

CPT David Shaha, MC US Army

Insomnia treatment in primary care

This initial discovery led to the creation of two classes of first generation antidepressants:

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling

Sleep Disorders: Assessment and Therapeutic Options

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Managing Insomnia Disorder A Review of the Research for Adults

Pharmacological Help for a Good Night s s Sleep. Thomas Owens, MD

Sleep disorders. Norbert Kozak

Psychopharmacology of Sleep Disorders

The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders What are functional GI disorders?

Psychopharmacology of Sleep Disorders

Consciousness, Stages of Sleep, & Dreams. Defined:

EEG Electrode Placement

Common Antidepressant Medications for Adults

Sleep and Insomnia 2/8/2018. Presented by. Marie Rataj, MSN, APRN, ANP. Objectives. Everything you wanted to know

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Xartemis XR (oxycodone / acetaminophen extended release)

New Patient Questionnaire

SLEEP DISORDERS IN HUNTINGTON S DISEASE. Gary L. Dunbar, Ph.D.

OXYCODONE IR (oxycodone)

Modern Management of Sleep Disorders. Case. Introduction. Topics Covered. Douglas C. Bauer, MD University of California, San Francisco

Mentoring Session: Participant Cases

Psychiatry curbside: Answers to a primary care doctor s top mental health questions

The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD

A Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment

Psychiatric Treatment of the Concussed Athlete

90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR

Antidepressant Selection in Primary Care

Linda Sobeski Farho, PharmD, BCPS Assistant Professor, Pharmacy Practice UNMC College of Pharmacy Critical Issues in Geriatrics June 24, 2010

Overview. Surviving shift work. What is the circadian rhythm? Components of a Generic Biological Timing System 31/10/2017

Insomnia. Learning Objectives. Disclosure 6/7/11. Research funding: NIH, Respironics, Embla Consulting: Elsevier

ANTIDEPRESSANT MEDICATION & RISK OF DEMENTIA

Sleep Wake Cycle in Depression

Anxiety Disorders- OCD. Peter Giacobbe MD FRCPC L. Ravindran MD FRCPC

Transcription:

Ruby Williams, M.D. Drugs, Alcohol and Sleep February 24, 2018

Objectives Describe pharmacology of commonly prescribed drugs for stimulants and hypnotics Brief review of common drugs that affect sleep and by the manner of how they do it either by Inducing sleepiness Inducing insomnia Sleep related side effects (ie RLS, EEG changes and parasomnias Brief review of how alcohol affects our sleep

Sleep and Neurotransmitters Wake Neurotransmitters Dopamine Norepinephrine Serotonin Acetycholine Histamine Orexin Sleep Neurotransmitters Adenosine Gaba

Stimulants Amphetamines Inhibit reuptake of dopamine and release presynaptic vesicles containing NE Leads to more wakefulness, less REM and SWS Bruxism, cardiovascular symptoms Methylphenidates Prevents reuptake of dopamine but does not release Less crash effect Modafinil Thought to be related to dopamine transport inhibition

Drug Comparison adderall Ritalin Provigil Nuvigil

Caffeine Adenosine: Increases as the day increases eventually stimulating sleepiness Caffeine: Antagonizes adenosine receptors Average person needs 200mg to have an effect

Benzo-like Drugs Act on GABA receptors Preferred over benzos less tolerance Decreases TST and sleep latency No clear change in sleep architecture and staging Possible increased sleep spindles SE Amnesia, non REM parasomnias (sleep eating), hallucinations Few respiratory effects

Sonata Ambien Lunesta

Benzodiazepams Modify GABA receptor to potentiate GABA effects Decrease sleep latency and WASO, Inc d TST Decrease REM sleep, Increase N2 Frequent spindles during N2 Suppresses N3 sleep Noteable side effects in the elderly Increased falls in elderly Tolerance and rebound/insomnia Mild respiratory depression

Other Sleep Aides Melatonin Naturally made in the pineal gland Decreases SL 4min and Sleep efficiency 2% Ramelteon Melatonin antagonist, low abuse FDA approved Mild improvement in TST and sleep latency Tasimelteon FDA approved for Non-24hr sleep wake d/o Suvorexant Orexin receptor antagonist FDA approved, decreases sleep latency and WASO Absolutely contraindicated in Narcolepsy

Tricyclic Antidepressants Serotonin and NE reuptake inhibition Muscarinic and histamine antagonist Decrease REM sleep Increase PLMs and RLS symptoms Sedating TCAs (anticholinergic/antihistamine) Decrease TST and sleep latency Amitriptyline, imipramine, doxepin Adrenergic TCAs May increase awakenings and decrease TST Nortriptyline

MAOI Monoamine oxidase inhibitors: prevent dopamine, serotonin and norepinephrine Side effects are daytime sleepiness and insomnia Marked decreased REM sleep

SSRI Selective serotonin reuptake inhibitor Decreased TST, Increased WASO, increased sleep latency Decreased REM, increased stage 1 Increased PLMS REM sleep w/o atonia Prozac eyes on EOG

Most stimulating: Prozac fluoxetine Zoloft- sertraline Paxil- paroxetine celexa- citalopram Lexapro- escitalopram Luvox-fluvoxamine Most sedating

SNRIs Serotonin and norepinephrine reuptake inhibitors Venlafaxine- Effexor Duloxetine- Cymbalta Multiple uses Pain- fibro or neuropathic, depression, anxiety Insomnia very common Watch when this medication is dosed! Dec d TST, Dec d REM, Inc d PLMs, Reports of RBD

Trazodone Serotonin antagonist and reuptake inhibitors Drowsiness is a SE and often used as a hypnotic Dec d SL, Inc d SWS, No change in REM Does not effect PLM or REM SE unwanted prolonged priapism

Buproprion Wellbutrin Inhibits dopamine and NE reuptake Does not really affect REM sleep Dec s PLMS Insomnia (consider depression with EDS)

Mirtazapine Antagonizes 5HT-2 and HT1 receptors Highly sedating Dec d sleep latency and inc d N3 Daytime sleepiness is a SE could use for insomnia RLS can get worse

Antipsychotics Multiple mechanisms Dopamine, 5HT, Ach, Histamine Sedating Inc TST and dec SL Inc SWS and dec REM Exacerbate RLS

Other Drugs Buspirone 5HT1-A partial agonist Non sedating anxiolytic Dec d REM sleep Donepizil Causes vivid dreams Insomnia due to increased cholinergic activity

Beta Blockade Common drug that can affect sleep Daytime fatigue, nightmares, insomnia Impairs melatonin production Propanolol is most associated with sleep disruption The more lipophilic the drug, the more sleep side effects

Alpha-2 Agonists Clonidine and methyldopa Sedation very common Usually goes away with time Nightmares and insomnia

Prazosin Alpha-1 antagonist Inc TST and increased REM sleep Reduces nightmares (key use) Great for PTSD related nightmares

Antihistamines H1 antagonists Benadryl (diphenhydramine),hydroxyzine Lipophilic and crosses blood barrier very easily Certrizine (Zyrtec) and loratadine (Claritin) hydrophilic thus less sedating

Opiates Very decreased amount of N3 sleep No clear effect on TST, however, in chronic users may lead to increase WASO Decreased respiratory drives especially at higher doses Can lead central sleep apneas Can lead to hypercapnia and hypoxia

Respiratory Drugs Prednisone Insomnia with increased doses, dec REM Pseudophedrine Insomnia Theophyline Insomnia and WASO Short acting beta agonists Insomnia

Alcohol and Sleep

Alcohol Alcohol-Related Deaths: An estimated 88,000 8 people (approximately 62,000 men and 26,000 women 8 ) die from alcohol-related causes annually, making alcohol the third leading preventable cause of death in the United States. The first is tobacco, and the second is poor diet and physical inactivity. 9 In 2014, alcohol-impaired driving fatalities accounted for 9,967 deaths (31 percent of overall driving fatalities). 10

Alcohol and Sleep Physiology Patient s given alcohol 30-60min before bedtime Effect: patient s blood alcohol content peaked at lights out Dose ranged from 0.16-1.0 gram per kilogram of body weight 1 Corresponded to 1-6 standard drinks 2 leading to breath alcohol of 0.15 1. WILLIAMS, H., AND SALAMY, A. Alcohol and sleep. In: Kissin, B., and Begleiter, H., eds. The Biology of Alcoholism. New York: Plenum Press, 1972. pp. 435-483. 2. A standard drink is defined as one 12-ounce bottle of beer or wine cooler, one 5-ounce glass of wine, and 1.5 ounces of 80 proof distilled spirits

Findings: Consistently effects the proportions of various sleep stages 1. Dose dependent suppression of REM sleep at the first half of the sleep period 1 Development o f REM rebound 2 during the second half of the night Overall amount of REM sleep in subjects receiving alcohol before sleep did not differ from subjects who did not drink alcohol 1 This was associated with the completed alcohol metabolism and elimination from the body 1 Increase in slow wave sleep with acute ingestion during first half of sleep 1

Recurrent ingestion after 3 nights led to tolerance of alcohol s sedative and sleep stage effects 1 The percentage of SWS and REM returned to normal The discontinuation of nightly alcohol led to REM rebound 1

PSG Effects Acute alcohol ingestion: First part of sleep: dec SOL & WASO, inc REM SL, dec REM Second part of sleep: inc WASO, dec N3, Inc REM Alcohol withdrawal: Inc SOL, Inc WASO, Dec TST, Dec N3, Dec REM SL and Inc REM (REM Rebound) Alcohol abstinence: Inc SOL, Dec TST, Inc WASO, Dec N3 (may be forever in alcoholics who remain sober)

Alcohol and OSA Acute ingestion can make snoring and AHI worse Decreased REM sleep in first part of the night decreases the longer events associated with REM sleep however, more severe desaturations and presumably longer events can occur the second part of the night

Alcohol and Sleep Disturbances Alcohol use: Inc nightmares and vivid dreams. Inc enuresis, RLS, sleep terrors/sleep walking, snoring and osa Acute alcohol withdrawal: Insomnia, frequent awakenings accompanied by headaches and diaphoresis. Vivid disturbing dreams. Alcohol abstinence: Sleep disturbance, including insomnia, can persist for several years. Dec TST with delirium tremens.

Relation to nocturnal sleep to daytime alertness In one study, young pilots drank alcohol between 6 p.m. and 9 p.m. in quantities sufficient to result in blood alcohol concentrations (BACs) of 0.10 and 0.12 percent right before bedtime. 1 The following morning, more than 14 hours after consuming alcohol and with BACs at 0, the performance of pilots in a flight simulator was impaired relative to their performance after consuming a placebo 1 Roehrs and colleagues gave studies alcohol before bedtime, goal of breath 0.06, and studied their performance the next day on MSLT checking their auditory vigilance, in which the participants had to respond to a certain sound, or divided attention tasks, in which the participants had to perform two tasks simultaneously 2 Alertness and divided attention was decreased, showing that alcohol indirectly affects daytime performance by affecting sleep. 2

Bottom Line About Alcohol Makes you feel good when you re drinking it, but you will pay for it later with: Exacerbation of snoring Sleep disturbances with second half of the night REM rebound Exacerbation of OSA Increased WASO Poor performance next day